Thomas Jefferson University

Michael Marmura

TitleAssoc Professor
InstitutionThomas Jefferson University
DepartmentNeurology
Address111 S. 11th Street
Philadelphia PA 19107
Phone215-955-2243
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rizzoli P, Marmura MJ, Robblee J, McVige J, Sacco S, Nahas SJ, Ailani J, De Abreu Ferreira R, Ma J, Smith JH, Dabruzzo B, Ashina M. Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials. J Headache Pain. 2024 Mar 11; 25(1):35. PMID: 38462625.
      Citations:    
    2. Yuan H, Natekar A, Park J, Lauritsen CG, Viscusi ER, Marmura MJ. Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis. Reg Anesth Pain Med. 2023 May 30. PMID: 37253638.
      Citations:    
    3. Starling AJ, Cowan RP, Buse DC, Diener HC, Marmura MJ, Hirman J, Brevig T, Cady R. Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trial. Headache. 2023 Jan 12. PMID: 36633219.
      Citations:    
    4. Klein BC, Miceli R, Severt L, McAllister P, Mechtler L, McVige J, Diamond M, Marmura MJ, Guo H, Finnegan M, Trugman JM. Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial. Cephalalgia. 2023 Jan; 43(1):3331024221128250. PMID: 36620892.
      Citations:    
    5. Cowan RP, Marmura MJ, Diener HC, Starling AJ, Schim J, Hirman J, Brevig T, Cady R. Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study. J Headache Pain. 2022 Sep 06; 23(1):115. PMID: 36068494.
      Citations:    
    6. Gottschalk C, Buse DC, Marmura MJ, Torphy B, Pavlovic JM, Dumas PK, Lalvani N, Blumenfeld A. The importance of an early onset of migraine prevention: an evidence-based, hypothesis-driven scoping literature review. Ther Adv Neurol Disord. 2022; 15:17562864221095902. PMID: 35662957.
      Citations:    
    7. Patel ZM, Holbrook EH, Turner JH, Adappa ND, Albers MW, Altundag A, Appenzeller S, Costanzo RM, Croy I, Davis GE, Dehgani-Mobaraki P, Doty RL, Duffy VB, Goldstein BJ, Gudis DA, Haehner A, Higgins TS, Hopkins C, Huart C, Hummel T, Jitaroon K, Kern RC, Khanwalkar AR, Kobayashi M, Kondo K, Lane AP, Lechner M, Leopold DA, Levy JM, Marmura MJ, Mclelland L, Miwa T, Moberg PJ, Mueller CA, Nigwekar SU, O'Brien EK, Paunescu TG, Pellegrino R, Philpott C, Pinto JM, Reiter ER, Roalf DR, Rowan NR, Schlosser RJ, Schwob J, Seiden AM, Smith TL, Soler ZM, Sowerby L, Tan BK, Thamboo A, Wrobel B, Yan CH. International consensus statement on allergy and rhinology: Olfaction. Int Forum Allergy Rhinol. 2022 04; 12(4):327-680. PMID: 35373533.
      Citations:    
    8. Najib U, Smith T, Hindiyeh N, Saper J, Nye B, Ashina S, McClure CK, Marmura MJ, Chase S, Liebler E, Lipton RB. Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial. Cephalalgia. 2022 Jan 09; 3331024211068813. PMID: 35001643.
      Citations:    
    9. Marmura MJ, Diener HC, Cowan RP, Tepper SJ, Diamond ML, Starling AJ, Hirman J, Mehta L, Brevig T, Cady R. Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache. Headache. 2021 Oct; 61(9):1421-1431. PMID: 34551130.
      Citations:    
    10. Hershey AD, Armand CE, Berk T, Burch R, Buse DC, Dougherty C, Marmura MJ, Minen MT, Robblee J, Schwarz HB. Updated process for American Headache Society Guidelines. Headache. 2021 Apr; 61(4):565-566. PMID: 33891346.
      Citations:    
    11. Marmura MJ. Comparing treatments in the emergency department: What works for migraine? Headache. 2021 Apr; 61(4):567-568. PMID: 33891347.
      Citations:    
    12. Silberstein SD, Cohen JM, Yang R, Gandhi SK, Du E, Jann AE, Marmura MJ. Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials. J Headache Pain. 2021 Jan 07; 22(1):2. PMID: 33413075.
      Citations:    
    13. Diener HC, Marmura MJ, Tepper SJ, Cowan R, Starling AJ, Diamond ML, Hirman J, Mehta L, Brevig T, Sperling B, Cady R. Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2. Headache. 2020 Dec 13. PMID: 33314079.
      Citations:    
    14. Marmura MJ, Lin T, Harris D, Ironi A, Rosen NL. Incorporating Remote Electrical Neuromodulation (REN) Into Usual Care Reduces Acute Migraine Medication Use: An Open-Label Extension Study. Front Neurol. 2020; 11:226. PMID: 32318014.
      Citations:    
    15. Evans RW, Burch RC, Frishberg BM, Marmura MJ, Mechtler LL, Silberstein SD, Turner DP. Neuroimaging for Migraine: The American Headache Society Systematic Review and Evidence-Based Guideline. Headache. 2019 Dec 31. PMID: 31891197.
      Citations:    
    16. Marmura MJ, Hou A. Inpatient Management of Migraine. Neurol Clin. 2019 Nov; 37(4):771-788. PMID: 31563232.
      Citations:    
    17. Marmura MJ. Triggers, Protectors, and Predictors in Episodic Migraine. Curr Pain Headache Rep. 2018 Oct 05; 22(12):81. PMID: 30291562.
      Citations:    
    18. Marmura MJ, Kumpinsky AS. Refining the Benefit/Risk Profile of Anti-Epileptic Drugs in Headache Disorders. CNS Drugs. 2018 Aug; 32(8):735-746. PMID: 30073584.
      Citations:    
    19. Starling AJ, Tepper SJ, Marmura MJ, Shamim EA, Robbins MS, Hindiyeh N, Charles AC, Goadsby PJ, Lipton RB, Silberstein SD, Gelfand AA, Chiacchierini RP, Dodick DW. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study). Cephalalgia. 2018 Jan 01; 333102418762525. PMID: 29504483.
      Citations:    
    20. Lauritsen CG, Marmura MJ. Current Treatment Options: Vestibular Migraine. Curr Treat Options Neurol. 2017 Sep 30; 19(11):38. PMID: 28965306.
      Citations:    
    21. Pomeroy JL, Marmura MJ, Nahas SJ, Viscusi ER. Ketamine Infusions for Treatment Refractory Headache. Headache. 2017 Feb; 57(2):276-282. PMID: 28025837.
      Citations:    
    22. Pringsheim T, Davenport WJ, Marmura MJ, Schwedt TJ, Silberstein S. How to Apply the AHS Evidence Assessment of the Acute Treatment of Migraine in Adults to your Patient with Migraine. Headache. 2016 Jul; 56(7):1194-200. PMID: 27322907.
      Citations:    
    23. Zhu S, Marmura MJ. Non-Invasive Neuromodulation for Headache Disorders. Curr Neurol Neurosci Rep. 2016 Feb; 16(2):11. PMID: 26750126.
      Citations:    
    24. Marmura MJ, Hernandez PB. High-altitude headache. Curr Pain Headache Rep. 2015 May; 19(5):483. PMID: 25795155.
      Citations:    
    25. Marmura MJ, Goldberg SW. Inpatient management of migraine. Curr Neurol Neurosci Rep. 2015 Apr; 15(4):539. PMID: 25704007.
      Citations:    
    26. Silberstein SD, Marmura MJ. Acute migraine treatment. Headache. 2015 Jan; 55(1):1-2. PMID: 25600717.
      Citations:    
    27. Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies. Headache. 2015 Jan; 55(1):3-20. PMID: 25600718.
      Citations:    
    28. Whiting AC, Marmura MJ, Hegarty SE, Keith SW. Olfactory acuity in chronic migraine: a cross-sectional study. Headache. 2015 Jan; 55(1):71-5. PMID: 25385519.
      Citations:    
    29. Marmura MJ. Safety of topiramate for treating migraines. Expert Opin Drug Saf. 2014 Sep; 13(9):1241-7. PMID: 25096056.
      Citations:    
    30. Marmura MJ, Monteith TS, Anjum W, Doty RL, Hegarty SE, Keith SW. Olfactory function in migraine both during and between attacks. Cephalalgia. 2014 Oct; 34(12):977-85. PMID: 24646836.
      Citations:    
    31. Marmura MJ, Silberstein SD. Headaches caused by nasal and paranasal sinus disease. Neurol Clin. 2014 May; 32(2):507-23. PMID: 24703542.
      Citations:    
    32. Hutchinson S, Marmura MJ, Calhoun A, Lucas S, Silberstein S, Peterlin BL. Use of common migraine treatments in breast-feeding women: a summary of recommendations. Headache. 2013 Apr; 53(4):614-27. PMID: 23465038.
      Citations:    
    33. Sachdev A, Marmura MJ. Metabolic syndrome and migraine. Front Neurol. 2012; 3:161. PMID: 23181051.
      Citations:    
    34. Marmura MJ, Young WB. Interictal pain in primary headache syndromes. Curr Pain Headache Rep. 2012 Apr; 16(2):170-4. PMID: 22249655.
      Citations:    
    35. Marmura MJ. Use of dopamine antagonists in treatment of migraine. Curr Treat Options Neurol. 2012 Feb; 14(1):27-35. PMID: 22012659.
      Citations:    
    36. Marmura MJ, Silberstein SD. Current understanding and treatment of headache disorders: five new things. Neurology. 2011 Feb 15; 76(7 Suppl 2):S31-6. PMID: 21321349.
      Citations:    
    37. Cole AK, Marmura MJ. Triptans: where things stand. Curr Treat Options Neurol. 2010 Sep; 12(5):454-63. PMID: 20842600.
      Citations:    
    38. Lovell BV, Marmura MJ. New therapeutic developments in chronic migraine. Curr Opin Neurol. 2010 Jun; 23(3):254-8. PMID: 20442572.
      Citations:    
    39. Marmura MJ, Nahas SJ. What might the ideal electronic medical record for migraine headache look like? Curr Pain Headache Rep. 2010 Jun; 14(3):233-7. PMID: 20425192.
      Citations:    
    40. Marmura MJ, Pello SJ, Young WB. Interictal pain in cluster headache. Cephalalgia. 2010 Dec; 30(12):1531-4. PMID: 20974600.
      Citations:    
    41. Lovell BV, Marmura MJ. Valproate semisodium ER for migraine and cluster headache prophylaxis. Expert Opin Drug Metab Toxicol. 2010 Apr; 6(4):495-504. PMID: 20298131.
      Citations:    
    42. Marmura MJ. Intravenous lidocaine and mexiletine in the management of trigeminal autonomic cephalalgias. Curr Pain Headache Rep. 2010 Apr; 14(2):145-50. PMID: 20425204.
      Citations:    
    43. Marmura MJ, Hopkins M, Andrel J, Young WB, Biondi DM, Rupnow MF, Armstrong RB. Electronic medical records as a research tool: evaluating topiramate use at a headache center. Headache. 2010 May; 50(5):769-78. PMID: 20236335.
      Citations:    
    44. Prakash S, Shah ND, Marmura MJ. Hemicrania continua unresponsive to indomethacin do exist. Cephalalgia. 2010 Jan; 30(1):123-5. PMID: 20511195.
      Citations:    
    45. Silberstein SD, Marmura MJ, Shaw J, Yu S. Headache prophylaxis with BoNTA: patient characteristics. Headache. 2010 Jan; 50(1):63-70. PMID: 19549156.
      Citations:    
    46. Marmura M. Hemicrania continua: factors predicting response? Headache. 2009 Jul; 49(7):1073. PMID: 19486176.
      Citations:    
    47. Marmura MJ, Abbas M, Ashkenazi A. Dynamic mechanical (brush) allodynia in cluster headache: a prevalence study in a tertiary headache clinic. J Headache Pain. 2009 Aug; 10(4):255-8. PMID: 19421708.
      Citations:    
    48. Marmura MJ. Systemic abnormalities in migraine: what comes first? Neurologist. 2009 Mar; 15(2):53-4. PMID: 19276781.
      Citations:    
    49. Rosen N, Marmura M, Abbas M, Silberstein S. Intravenous lidocaine in the treatment of refractory headache: a retrospective case series. Headache. 2009 Feb; 49(2):286-91. PMID: 19222600.
      Citations:    
    50. Marmura MJ, Passero FC, Young WB. Mexiletine for refractory chronic daily headache: a report of nine cases. Headache. 2008 Nov-Dec; 48(10):1506-10. PMID: 18793209.
      Citations:    
    51. Young WB, Marmura M, Ashkenazi A, Evans RW. Expert opinion: greater occipital nerve and other anesthetic injections for primary headache disorders. Headache. 2008 Jul; 48(7):1122-5. PMID: 18687084.
      Citations:    
    52. Marmura M, Solomon S. Headache stigmata. Cluster headache. Headache. 2007 Sep; 47(8):1245-6, 1246-7. PMID: 17883546.
      Citations:    
    Marmura's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (105)
    Explore
    _
    Co-Authors (10)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _